Investor Relations Senior Financial Analyst (San Diego/Hybrid) at Illumina

San Diego, California, United States

Illumina Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, HealthcareIndustries

Requirements

  • Typically requires a minimum of 5 years of related finance experience with a Bachelor’s degree; or 3 years and a Master's degree; MBA (preferred)
  • Finance background required; exposure to investor relations, equity research, or corporate finance strongly preferred
  • Industry experience (life sciences, diagnostics, biotech, etc.) a plus but not required
  • Familiarity with financial concepts (inferred from role and finance background)
  • Reside in the San Diego area and be able to commute to corporate offices
  • Polished, professional presence and strong communication skills for interactions with senior leadership, investors, and Wall Street analysts

Responsibilities

  • Drive preparation of quarterly earnings and investor conference deliverables, including drafting scripts, Q&A, and presentations for senior management, while ensuring alignment across internal stakeholders
  • Serve as a primary liaison for investors and sell-side analysts, managing inquiries while collaborating with internal subject-matter experts to deliver accurate and timely responses that align with the corporate narrative
  • Summarize market insights and equity research for distribution to internal stakeholders, including senior management and the Board of Directors
  • Monitor and benchmark peer company performance by reviewing earnings, investor events, and disclosures; deliver actionable analyses that influence Illumina’s investor messaging and shape leadership narratives
  • Oversee maintenance and communication of the company’s consensus model, investor ownership changes, and peer benchmarking analyses
  • Lead strategy, planning, and execution for investor-facing events (e.g. earnings calls, conferences, investor days, non-deal roadshows, investor meetings), partnering with internal and external stakeholders to ensure seamless coordination
  • Manage and analyze investor interactions, ensuring accurate documentation and delivering insights on engagement trends to senior leadership
  • Oversee operational workflows for the IR team, including IR mailbox management, calendar coordination, travel planning, expense reporting, and management of shared team resources
  • Identify and implement process improvements by streamlining workflows, automating tasks, and enhancing team tools
  • Drive cross-functional projects and strategic initiatives, contributing to investor strategy, C-suite communications, and operational priorities

Skills

Financial Analysis
Investor Relations
Earnings Preparation
Q&A Drafting
Presentations
Reporting
Market Insights
Peer Analysis
Cross-Functional Coordination
Communication

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI